APEX1 and neurodegenerative disease: Most studies have focused on the role of APE1 on cognitive function and neurodegenerative diseases and there is scarce literature on the role of this enzyme (and the BER pathway) on physical disability despite the important role of maintenance of genomic stability in aging.